PARP7 knockdown leads to a reduction of growth, migration and invasion of ovarian cancer cells (Palavalli Parsons et al., 2021), indicating inhibition of PARP7 may have a positive therapeutic effect on ovarian cancer. This evidence concerns the gene TIPARP and ovarian cancer.